COVID 19.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Definite diagnosis of covid 19 with PCR Hospitalization during the acute phase of the disease Lung involvement with a typical pattern of covid 19 in chest X ray or chest CT scan Being clinically stable Being able to understand and perform the virtual respiratory exercises as given to them in the study Age > 18 and < 60 years
Exclusion criteria
Exclusion criteria: COPD, asthma and any other respiratory disease Neuromuscular disorders that affect lung function History of ischemic heart disease, congestive heart failure and uncontrolled hypertension Asymptomatic carriers Sever comorbid conditions Disagree to participate in the study Lack of access to the internet and virtual applications
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The perceived dyspnea severity during daily activities. Timepoint: Before intervention and 8 weeks after study. Method of measurement: Medical Research Council Scale.;The severity of dyspnea. Timepoint: Before intervention and 8 weeks after study. Method of measurement: Modified Borg Scale.;General health-related quality of life. Timepoint: Before intervention and 8 weeks after study. Method of measurement: Short-Form 36 (SF-36).;Psychological state and mood disorder. Timepoint: Before intervention and 8 weeks after study. Method of measurement: The Hospital Anxiety and Depression Scale (HADS). | — |
Countries
Iran (Islamic Republic of)
Contacts
Shiraz University of Medical Sciences